Your 5% appears to be a reasonable estimate regarding dividends.
On 2 March 2020, I studied dividends from recent years of the top 20 pharmaceutical companies, who had an average market cap of 129.7B, and their average dividend/revenue was 8.2%.
And like you, every projection I make looks superlative.